Sabah Signs Mou With Private Firm To Obtain Sinopharm Vaccine

---

 
Rusdin Riman (2nd from left) with Steven Kuah after the signing of the MoU today.KOTA KINABALU: The Sabah government and Kanger International Bhd today signed a memorandum of understanding (MoU) to obtain the supply of the Sinopharm Covid-19 vaccine for people in the state.
Under the MoU, the state government agreed to appoint the company as the sole distributor of the Sinopharm vaccine for Sabah after its usage has been approved for use in the country, while Kanger International will obtain the vaccine to be supplied to the state government.
Sabah finance ministry permanent secretary Rusdin Riman and Kanger International executive director Steven Kuah signed the MoU at the Sabah state administrative centre, here, today.
Kuah told reporters that the company would obtain approval from Putrajaya through the National Pharmaceutical Regulatory Agency (NPRA) before bringing the supply into Sabah.
“The process of registering the Sinopharm vaccine (with NPRA) has started and we hope to receive some good news on its approval soon.
“We believe that cooperation between the public and private sectors will be beneficial and speed up the vaccination exercise in Malaysia,” he said, adding that the total number of doses to be supplied to Sabah would be decided on later.
Kuah said the company viewed this initiative as important to support and complement the government’s efforts towards achieving herd immunity in Malaysia to curb the spread of Covid-19.
Currently, only three types of Covid-19 vaccines are being used in Malaysia, namely, Pfizer-BioNTech, Sinovac and AstraZeneca. - FMT

---